Consultancy and solutions that help pharma companies meet every regulatory, clinical and safety standard.
Insight is Egypt’s market leader in safety and regulatory solutions, trusted by leading pharmaceutical companies across the MENA region for pharmacovigilance, clinical research, regulatory affairs and digital solutions for the pharma industry.
Trusted by leading pharmaceutical companies in the MENA region
Digital Solutions for the Pharma Industry
We provide digital solutions and build automation systems for pharmaceutical companies, from safety database software to training, clinical data and registration dossiers. Vigipx, our ICH E2B (R3) safety database, is the one most pharmacovigilance teams in Egypt rely on.
Vigipx Safety Database · Insight Academy · Insight EDC · Dossier Hub · Automation and electronic archiving
Egypt’s number one digital solutions for the pharma industry
We automate pharmaceutical companies from end to end. Our team sets up complete electronic systems and electronic archiving, from safety case processing and training records to clinical data and registration dossiers, so your documents and data live in one secure, organised place instead of on paper and in spreadsheets.
Every company works differently, so we tailor each system to yours.
Collaboration and integrity, built into every project
Trusted by leading pharmaceutical companies in Egypt, we combine deep regulatory knowledge with world-class technology. We deliver real value to our clients, and every project delivers results you can see and measure.
Good practice in every discipline
Every service runs under our documented quality management system, with written procedures, trained specialists and regular internal audits, so the quality you get does not depend on who picks up the file.
Technology we own
We have designed, built and owned our digital solutions since 2020, and we update them regularly so they keep pace with the highest standards in the world.
Global standards
Our pharmacovigilance follows GVP, our clinical studies follow ICH GCP, and our regulatory work follows the ICH CTD structure, in line with EMA, FDA and WHO guidance. Our digital solutions meet ICH E2B (R3), FDA 21 CFR Part 11 and EU Annex 11.
From our experts
How to choose a CRO in Egypt: what to check before you sign
The best CRO for your study is the one that fits its phase, its patients and its approvals. These are the questions we would ask if we were the sponsor.
PharmacovigilanceWhat a QPPV does, and why every marketing authorization holder needs one
The Qualified Person for Pharmacovigilance is the one person who answers for the safety system behind your products. Here is what the role covers in practice.
QualityFive steps to get ready for a pharmacovigilance inspection
Inspections go well when the system is in order long before the notice arrives. These five steps cover what inspectors usually want to see first.




















































